SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energys strong Q3 results and raised outlook were overshadowed by a sharp share decline, with traders focused on negative cash flow, heavy investment spending and valuation concerns amid weakness in AI-linked stocks. Bulls called the selloff an overreaction and looked to buy the dip, while bears argued the price had run ahead of fundamentals.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokias Q3 results beat expectations, but shares sold off sharply as traders focused on reduced free-cash-flow conversion guidance, negative cash flow, higher restructuring costs and managements warning of structural supply-cost inflation. Bulls see the drop as an overreaction given strong AI and cloud demand, while bears argue cash generation concerns outweigh the earnings beat.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention after a sharp semiconductor-sector selloff, fueled by supply-chain concerns flagged by LAM Research and broader doubts about AI spending and chip valuations; its 3x leverage magnifies the decline. Traders are split between buying an oversold dip and expecting further losses, with many warning that volatility could remain high.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following segments: Walmart U.S., Walmart International, and Sam's Club U.S. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club U.S. segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmarts sharp rally is drawing attention after Deutsche Bank upgraded the stock to Buy, citing a more favorable outlook and potential for improving margins; traders are also pointing to defensive-sector flows amid weakness in technology stocks. Bulls are leaning into the momentum and call buying, while bears argue the valuation is stretched and the move could reverse if money rotates back to tech.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Trading-platform outages and Thinkorswim login, order-entry, and pricing problems are driving the discussion, with traders frustrated about being unable to manage positions and some considering moving their accounts to other brokers. Complaints are widespread, though a few users report that access was restored or that their platforms were working.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digitals strong quarterly results and upbeat outlook have been overshadowed by a sharp share-price decline, prompting debate over whether investors are pricing in elevated spending, peak-cycle earnings and broader weakness in AI-linked stocks. Bulls point to durable AI-driven storage demand and pricing strength, while bears question how sustainable the cycle is.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

A sharp Nasdaq- and technology-led selloff has weighed on TQQQ, with traders pointing to inflation and interest-rate worries alongside concerns about AI spending and chip stocks. The community is split between buying an oversold dip for a relief bounce and warning that bearish momentum could bring further losses, amplified by the funds 3x daily leverage.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

CFO Ryan Fiedlers departure triggered a sharp selloff, with some traders speculating about undisclosed financial problems while others called the reaction excessive. The company said the departure involved no disagreement and indicated first-quarter revenue and adjusted EBITDA would exceed the high end of guidance, prompting debate over whether strong business trends outweigh lingering uncertainty.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Phase 3 melanoma-vaccine results leaked ahead of the ESMO presentation, triggering a sharp selloff despite showing reduced recurrence risk when the vaccine was combined with Keytruda. Traders are divided between calling it a sell-the-news reaction after a steep run-up and arguing that the results fell short of elevated expectations, with uncertainty about commercial prospects and efficacy beyond melanoma.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Zips sharp selloff after fraud and credit-quality concerns is prompting traders to debate whether weakness will spill over to Affirm and the broader buy-now-pay-later sector. Some see Affirm as unfairly caught in the sector pullback and point to its exclusive Sams Club pay-over-time deal as a positive counterpoint.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Halozyme to Report Third Quarter 2026 Financial and Operating Results

Halozyme to Report Third Quarter 2026 Financial and Operating Results Halozyme to Report Third Quarter 2026 Financial and Operating ResultsPR NewswireSAN DIEGO, Oct. 22, 2026 SAN DIEGO, Oct. 22, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced it will...

The Zacks Analyst Blog Highlights Chord Energy, Halozyme, Sezzle, SanDisk and Teradyne

CHRD, HALO, SEZL, SNDK and TER boast strong margins and growth prospects, with earnings catalysts ahead as October 2026 results roll in.

5 Strong Buy Growth Stocks With High Margins to Grab Before Earnings

Five Strong Buy stocks stand out ahead of earnings, combining high operating margins, revenue growth and exposure to AI, healthcare, energy and digital payments.

ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook

Elevance Health beats Q3 EPS estimate by 50% as Carelon grows despite declining medical membership, and lifts its 2026 underlying earnings baseline to $26.75.

Are Medical Stocks Lagging  Climb Bio, Inc. (CLYM) This Year?

Here is how Climb Bio, Inc. (CLYM) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.

The Zacks Analyst Blog Highlights Ross Stores, Roku, APA, Corcept Therapeutics and Halozyme Therapeutics

Ross Stores, Roku, APA, Corcept Therapeutics and Halozyme Therapeutics earn top Zacks rankings, backed by growth drivers ranging from streaming ads to drug demand.

Zacks.com featured highlights include Halozyme Therapeutics, GigaCloud Technology, Lindblad Expeditions, Permian Resources and Chevron

Halozyme Therapeutics, GigaCloud Technology, Lindblad Expeditions, Permian Resources and Chevron stand out for strong share gains and rising earnings estimates under a relative price strength strategy.

5 Stocks to Buy Using the Relative Price Strength Strategy

HALO, GCT, LIND, PR and CVX stand out as relative strength picks amid market volatility, backed by strong price performance and upbeat earnings estimates.

Roche Gets FDA Approval for Enspryng in Thyroid Eye Disease

RHHBY wins FDA approval for Enspryng in thyroid eye disease, offering the first and only at-home subcutaneous treatment option for patients.

KRYS Reports Positive Early Data for KB113 in Gorlin Syndrome

Krystal Biotech reports promising early results for KB113, with tumor regression seen in more than 80% of assessed lesions in an early Gorlin syndrome study.

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Halozyme Therapeutics Inc.

These Two Biotech Stocks Hit Fresh 52-Week Highs Today – NTRA Clocks Best Day In Nearly 20 Months

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Natera reported second-quarter revenue of $752.8 million, well above Wall Street estimates of $661.3 million, according to Fiscal.ai.</li><li>BTIG raised its price target on NTRA to $320 from $290, while JPMorgan increased its target to $360 from $315.</li><li>Leerink upgraded Halozyme Therapeutics stock to ‘Outperform’ from ‘Market Perform’ and raised its price target to $110 from $83, according to TheFly.</li></ul>Shares of Natera (NTRA) and Halozyme Therapeutics (HALO) hit fresh 52-week highs on Friday, with NTRA recording its biggest single-day gains since November 2024, after analysts raised their price targets on the stock, following better-than-expected second-quarter results.At the time of writing, <a href="https://stocktwits.com/symbol/NTRA">NTRA shares</a> traded 19.2% higher, having hit an intraday high of $322, while <a href="https://stocktwits.com/symbol/HALO">HALO stock</a> was up 17.6%, after hitting an intraday high of $100.7.<h2 class="st-heading-2">Natera Raises FY2026 Revenue Outlook</h2>Natera’s second-quarter earnings beat and increased full-year 2026 revenue outlook were followed by price target raises by BTIG and JPMorgan on Friday.Natera reported second-quarter revenue of $752.8 million, up 37.7% from a year earlier and well above Wall Street estimates of $661.3 million, according to Fiscal.ai. The company reported a net loss of $0.47 per share, narrower than consensus estimates of a loss of $0.51 per share.The company also raised its 2026 revenue guidance to $2.85 billion to $2.91 billion, up from its previous forecast of $2.74 billion to $2.82 billion.BTIG raised its price target to $320 from $290, citing strong revenue growth, record Signatera testing volumes and higher guidance. Signatera is Natera’s proprietary testing method to analyze tumors.JPMorgan increased its target to $360 from $315, calling it an “exceptional” quarter for Signatera and adding that the company’s long-term growth opportunities remain underappreciated.Retail sentiment surrounding NTRA on Stocktwits changed to ‘neutral’ from ‘bearish’ over the past 24 hours, amid ‘high’ message volumes. The stock has gained more than 28% so far in 2026.<h2 class="st-heading-2">Wall Street Bets On&nbsp;Halozyme’s Drug Delivery Technology</h2>Following better-than-expected second-quarter earnings, Leerink upgraded Halozyme Therapeutics stock to ‘Outperform’ from ‘Market Perform’ and raised its price target to $110 from $83, according to The Fly.On Thursday, Halozyme posted a 48% jump in Q2 revenue to $481 million, well above Wall Street estimates of $402.3 million, according to Fiscal.ai. Royalty revenue came in at $307.7 million, while earnings of $2.28 per share also beat analysts' expectations of $1.82.Leerink said recent licensing deals for its patented drug delivery technology Enhanze reinforce its view that drugmakers are unlikely to develop competing technologies in-house after patent expiration in 2029.Separately, Wells Fargo raised its price target to $95 from $75, saying higher royalty revenue from Ocrevus' subcutaneous rollout and upcoming Enhanze launches provide additional room for growth.Retail sentiment surrounding HALO on Stocktwits flipped to ‘bullish’ from ‘bearish’ over the past 24 hours, amid ‘high’ message volumes. The stock has gained more than 43% so far this year.Also read: <a href="https://stocktwits.com/news-articles/default/equity/rdw-stock-gains-more-than-55-in-record-breaking-week-here-s-everything-that-drove-the-super-run/cZoffIDRJ9Z">RDW Stock Gains More Than 55% In Record-Breaking Week – Here’s Everything That Drove The Super Run</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Top 5 trending stocks retail is focused on now

Natera and Halozyme Therapeutics saw gains above 15%, led by bullish Wall Street commentary after better-than-expected second-quarter results.

Natera Inc

Very bullish

Cautiously bullish

Cautiously bearish

Very bearish

Stocktwits sentiment on $SPY just hit its lowest level of the year. How are you feeling about the market right now?

Stocktwits

 just hit its lowest level of the year. How are you feeling about the market right now?

Current Price	$124.54
Prev Close	$124.83
Open	$124.72
Dividend Yield	0.00%
50-Day Moving Average	$110.64
Beta	0.68
Avg. Volume	2.41M
PE Ratio	37.21

52-Week High	$125.43
52-Week Low	$61.23
Market Capitalization	$14.14B
EPS (Annual)	$2.56
Price to Book	98.94
Revenue Per Employee	$3.3M

Feed

News

Sentiment

Earnings

Fundamentals

Info

HALO Fundamentals